Clinical Trial Update: Combined Intraperitoneal Chemotherapy Regimen After Optimal Interval Surgery in Advanced Ovarian Cancer: BICOV-1 (Bidirectional Chemotherapy in Ovarian Cancer) [NA]

View source ↗

Summary

Clinical trial update for the BICOV-1 study evaluating bidirectional intraperitoneal chemotherapy after optimal interval surgery in advanced ovarian cancer; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia | Conditions: Ovarian Cancer | NA | Status: RECRUITING